In a gripping new release from Skyhorse Publishing, molecular biologist and whistleblower Becky McClain lays bare her harrowing journey in "Exposed," a book that promises to shake the foundations of ...

Patients with uveal melanoma may respond to T-cell therapy directed at an antigen that is highly expressed in the tumors, ...

A patient dosed in the MAGNITUDE study has suffered a Grade 4 liver transaminases and increased total bilirubin.

LONDON (Reuters) -Swiss drugmaker Novartis is exploring options to add more medicines to its direct-to-patient platform that is expected to launch in the U.S. on November 1, CEO Vas Narasimhan told ...

The new Moderna COVID vaccine, mNexspike, is approved for adults 65 and older and people 12 to 64 with an underlying medical ...

Gig-based and freelance creatives in Dallas County can now enroll in a health and wellness program catered to local artists ...

The coming flu season is the clearest indication yet that biopharma’s long-standing assumptions about predictability, ...

Novartis' blockbuster heart treatment Entresto saw sales growth stall in the third quarter of the year, dragging the Swiss ...

By Ludwig Burger and Bhanvi Satija FRANKFURT (Reuters) -Swiss drugmaker Novartis met third-quarter profit forecasts on ...

When investors seek to inject growth momentum into their portfolios, tech stocks are often the first choice. Companies like ...

Members of the 2024 bioprocessing training cohort. Photo courtesy of UNCP PEMBROKE — UNC Pembroke will offer a free, two-week bioprocessing course to prepare individuals for entry-level roles in the ...

The FDA announced a nationwide recall of over 140,000 bottles of a prescription cholesterol medication due to “failed ...